Vascular occlusion results from
thrombosis, embolism, stenosis, (as in atherosclerosis), vascular
compression, intravascular sludging or coagulation, and vasoconstriction (
for instance in hypertensive retinopathy and migraine).
Acute retinal
vascular occlusive disorders collectively constitute one of the major
causes of blindness or seriously impaired vision, and yet there is
marked controversy on their pathogeneses, clinical features and
particularly their management. This is because the subject is plagued
by multiple misconceptions. These include that: (i) various acute
retinal vascular occlusions represent a single disease; (ii)
estimation of visual acuity alone provides all the information
necessary to evaluate visual function; (iii) retinal venous occlusions
are a single clinical entity; (iv) retinal vein occlusion is
essentially a disease of the elderly and is not seen in the young; (v)
central retinal vein occlusion (CRVO) is one disease; (vi) fluorescein
fundus angiography is the best test to differentiate ischemic from
nonischemic CRVO; (vii) the site of occlusion in CRVO is invariably at
the lamina cribrosa; (viii) clinical picture of CRVO is often due to
compression or strangulation of the central retinal vein (CRV) in the
lamina cribrosa and not its occlusion; (ix) an eye can develop both
CRVO and central retinal artery occlusion (CRAO) simultaneously; (x)
every eye with CRVO is at risk of developing neovascular glaucoma;
(xi) lowering intraocular pressure (IOP) helps to improve retinal
circulation in an eye with CRVO; (xii) every patient with retinal vein
occlusion should have complete hematologic and coagulation evaluation;
(xiii) the natural history of CRVO does not usually involve
spontaneous visual improvement; (xiv) management of CRVO is similar to
that of venous thrombosis anywhere else in the body, i.e. with aspirin
and/or anti-coagulants; (xv) fibrinolytic agents can dissolve an
organized thrombus in the CRV; (xvi) it is beneficial to lower blood
pressure in patients with CRVO; (xvii) panretinal photocoagulation
used in ischemic retinal venous occlusive disorders has no deleterious
side-effects; (xviii) glaucoma or ocular hypertension can cause branch
retinal vein occlusion; (xix) branch retinal vein occlusion can cause
neovascular glaucoma; (xx) in eyes with CRAO, the artery is usually
not completely occluded; (xxi) CRAO is always either embolic or
thrombotic in origin; (xxii) amaurosis fugax is always due to retinal
ischemia secondary to transient retinal arterial embolism; (xxiii)
asymptomatic plaque(s) in retinal arteries do not require a detailed
evaluation; (xxiv) retinal function can improve even when acute
retinal ischemia due to CRAO has lasted for 20h or more; (xxv) CRAO,
like ischemic CRVO, can result in development of ocular
neovascularization; (xxvi) panretinal photocoagulation is needed for
"disc neovascularization" in CRAO; (xxvii) fibrinolytic agents are the
treatment of choice in CRAO; (xxviii) there is no chance of an eye
with retinal arterial occlusion having spontaneous visual improvement;
(xxix) absence of any abnormality on Doppler evaluation of the carotid
artery or echography of the heart always rules out those sites as the
source of embolism; and (xxx) absence of an embolus in the retinal
artery means the occlusion was not caused by an embolus. The major
cause of all these misconceptions is the lack of a proper
understanding of basic scientific facts related to the various
diseases. The objective of this paper is to discuss these
misconceptions, based on these scientific facts, to clarify the
understanding of these blinding disorders, and to place their
management on a rational, scientific basis.
Thrombosis of the
ocular vessels may accompany disease of these vessels, as in giant cell arteritis.
Certain
disorders of the heart, and of major vessels such as the carotid arteries,
predispose to emboli that lodge in the retina and are evident on funduscopic examination at points of vascular bifurcation.
The detection
of fat, air, and other emboli within the retina may aid in the clinical
diagnosis of embolization.
A frequent site of embolic obstruction of the
central retinal artery is that portion of the sclera which is perforated
for the passage of the optic nerve (lamina cribrosa), where the arterial
lumen is narrower than in the orbital portion of the artery.
The effects
of vascular obstruction depends upon the size of the vessel involved, the
degree of resultant ischemia, and the nature of the embolus.
Small emboli
often do not interfere with retinal function, while septic emboli may
cause foci of ocular infection.
Ischemia of any cause deprives the retina
of oxygen and other essential metabolites and frequently results in the
appearance of white fluffy patches that resemble cotton (“cotton-wool
patches”) on opthalmoscopic examination.
These
spots, which are generally round and seldom wider than the optic disc,
consist of aggregates of various swollen axons in the nerve fiber layer of
the retina.
The affected
axons contain numerous degenerated mitochondria and other dense bodies
related to the lysosomal system that accumulate because of impaired
axoplasmic flow.
Histologically,
cross sections of the individual swollen axons resemble cells (“cytoid
bodies”).
Cotton-wool
spots are reversible if the circulation is restored in time.
Combined occlusion of the central retinal artery and vein.Jpn
J Ophthalmol. 1994;38(2):202-7.
A 56-year-old
man, complaining of sudden visual loss in his left eye, demonstrated
cream-colored retinal edema along a macular branch of the central
retinal artery, overall delay of fluorescence in angiography and
general depression of the central visual field, which were
interpreted as the incomplete form of central retinal artery
occlusion (CRAO) mimicking cilioretinal or branch retinal artery
occlusion. After receiving paracentesis and fibrinolytic agents, the
patient recovered his vision gradually, while the ophthalmoscopic
findings progressed to show central retinal vein occlusion (CRVO)
changes consisting of dilated and tortuous retinal veins and
scattered intraretinal hemorrhages. The condition associated with
the retinal edema indicated combined obstruction of the central
retinal artery and the central retinal vein (combined CRAO/CRVO).
Six months later, both the ocular fundus and the vision returned to
normal. The similar cases in Japanese literature in which
ophthalmoscopic findings of combined CRAO/CRVO was followed by
aggravation of CRVO changes with or without recovery of vision were
reviewed.